Renergen (JSE:REN) FCF Margin % : -524.21% (As of Aug. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Renergen FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Renergen's Free Cash Flow for the six months ended in Aug. 2024 was R-134.25 Mil. Renergen's Revenue for the six months ended in Aug. 2024 was R25.61 Mil. Therefore, Renergen's FCF Margin % for the quarter that ended in Aug. 2024 was -524.21%.

As of today, Renergen's current FCF Yield % is -27.06%.

The historical rank and industry rank for Renergen's FCF Margin % or its related term are showing as below:

JSE:REN' s FCF Margin % Range Over the Past 10 Years
Min: -14642.81 Med: -3289.21 Max: -1025.27
Current: -1025.27

During the past 8 years, the highest FCF Margin % of Renergen was -1025.27%. The lowest was -14642.81%. And the median was -3289.21%.

JSE:REN's FCF Margin % is ranked worse than
97.12% of 939 companies
in the Oil & Gas industry
Industry Median: 3.62 vs JSE:REN: -1025.27

Renergen FCF Margin % Historical Data

The historical data trend for Renergen's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Renergen FCF Margin % Chart

Renergen Annual Data

Trend

Feb17

Feb18

Feb19

Feb20

Feb21

Feb22

Feb23

Feb24

FCF Margin %

Get a 7-Day Free Trial

-13,455.26

-10,949.19

-14,642.81

-4,031.15

-1,235.10

Renergen Semi-Annual Data
	Aug16	Feb17	Aug17	Feb18	Aug18	Feb19	Aug19	Feb20	Aug20	Feb21	Aug21	Feb22	Aug22	Feb23	Aug23	Feb24	Aug24
FCF Margin %	Get a 7-Day Free Trial												-22,884.85	-1,999.76	-740.87	-3,495.25	-524.21

Competitive Comparison of Renergen's FCF Margin %

For the Oil & Gas E&P subindustry, Renergen's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Renergen's FCF Margin % Distribution in the Oil & Gas Industry

For the Oil & Gas industry and Energy sector, Renergen's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Renergen's FCF Margin % falls into.

Renergen FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Renergen's FCF Margin for the fiscal year that ended in Feb. 2024 is calculated as

FCF Margin	=	Free Cash Flow (A: Feb. 2024 )	/	Revenue (A: Feb. 2024 )
	=	-357.587	/	28.952
	=	-1,235.10 %

Renergen's FCF Margin for the quarter that ended in Aug. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Aug. 2024 )	/	Revenue (Q: Aug. 2024 )
	=	-134.245	/	25.609
	=	-524.21 %

Renergen FCF Margin % Related Terms

Thank you for viewing the detailed overview of Renergen's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Renergen Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Energy » Oil & Gas » Renergen Ltd (JSE:REN) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

RGNNF:USA 9960:Germany RLT:Australia

Address

25 Minerva Avenue, Sandton Gate, Glenadrienne, Sandton, ZAF, 2196

Website

https://www.renergen.co.za

Renergen Ltd is an investment holding company focused on the alternative and renewable energy sectors in South Africa and sub-Saharan Africa. Its reportable segments are the Corporate Head office where all investment decisions are made; Tetra4 which explores, produces, and sells LNG in South Africa; Cryovation which has developed Cryo-VaccTM technology, and enables the safe transportation of vaccines and biologics at extremely low temperatures without the need for electrical power; and the Renergen U.S segment which assists with various fundraising and business development activities of the Group in the U.S market. The majority of the company's revenue is generated from the Tetra4 segment.